Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Cheng

Showing results (511-520 of 557) with videos related to

Pageof 56
Sort By:
Gut|January 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver diseaseYu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng, et al.
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Oncotarget|November 2, 2017
Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinomaZe-Han Liu, Qi Zhang, Yi-Jie Ding, et al.
Zhonghua Yi Xue Za Zhi|August 5, 2003
[Effects of mifepristone of different doses on emergency contraception, a randomized double-blind study]Bi-lian Xiao, H von Hertzen, Heng Zhao, et al.
Cancer Cell|April 25, 2025
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclastsJia-Nan Cheng, Zheng Jin, Chunxia Su, et al.
The Journal of Pathology|July 12, 2017
Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virusWen-Chun Liu, I-Chin Wu, Yen-Chien Lee, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in TaiwanMing-Ching Shen, Sheng-Chieh Chou, Shyh-Shin Chiou, et al.
Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi|June 13, 2003
Childhood Langerhans cell histiocytosis increased during El Niño 1997-98: a report from the Taiwan Pediatric Oncology GroupRong-Long Chen, Kuo-Sin Lin, Wan-Hui Chang, et al.
Clinical and Molecular Hepatology|October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseasesPin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Pageof 56

Showing results (511-520 of 557) with videos related to

Sort By:
Pageof 56
Gut|January 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver diseaseYu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng, et al.
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Oncotarget|November 2, 2017
Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinomaZe-Han Liu, Qi Zhang, Yi-Jie Ding, et al.
Zhonghua Yi Xue Za Zhi|August 5, 2003
[Effects of mifepristone of different doses on emergency contraception, a randomized double-blind study]Bi-lian Xiao, H von Hertzen, Heng Zhao, et al.
Cancer Cell|April 25, 2025
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclastsJia-Nan Cheng, Zheng Jin, Chunxia Su, et al.
The Journal of Pathology|July 12, 2017
Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virusWen-Chun Liu, I-Chin Wu, Yen-Chien Lee, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in TaiwanMing-Ching Shen, Sheng-Chieh Chou, Shyh-Shin Chiou, et al.
Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi|June 13, 2003
Childhood Langerhans cell histiocytosis increased during El Niño 1997-98: a report from the Taiwan Pediatric Oncology GroupRong-Long Chen, Kuo-Sin Lin, Wan-Hui Chang, et al.
Clinical and Molecular Hepatology|October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseasesPin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Pageof 56